Page last updated: 2024-10-30

metformin and Eye Disorders

metformin has been researched along with Eye Disorders in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nahar, N1
Mohamed, S1
Mustapha, NM1
Lau, S1
Ishak, NIM1
Umran, NS1

Other Studies

1 other study available for metformin and Eye Disorders

ArticleYear
Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:3

    Topics: Animals; Claudin-1; Diabetes Complications; Diabetes Mellitus, Experimental; Eye Diseases; Glutathio

2021